Cingulate submitted its New Drug Application (NDA) for CTx-1301 to the FDA, targeting the ADHD market, with an NDA acceptance decision expected in late 2025. Operating expenses increased for the three ...

A case study published in Frontiers in Psychiatry details how a 28-year-old man with Tourette syndrome (TS) and ADHD ...

I recently asked myself if I'll still have a healthy brain as I get older. I hold a professorship at a neurology department. Nevertheless, it is difficult for me to judge if a particular brain, ...

Alora Pharmaceuticals, LLC, the parent company of Vertical Pharmaceuticals, LLC, a leading pharmaceutical company committed to advancing access to high-quality therapies, announces the publication of ...

What Happened: Hudson's decision to sell 7,457 shares of Supernus Pharmaceuticals was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday. The total value of the ...

A nationwide study from Finland provides evidence that adults diagnosed with attention-deficit hyperactivity disorder (ADHD) ...

UC Davis Health researchers found that many autistic children also meet criteria for ADHD, emphasizing the importance of ...

Paracetamol, also known as acetaminophen, has long been considered the safest pain relief option during pregnancy. However, a ...